Evidence map›Paper›PMID 40395386›Full record

ArticleJournal of clinical and translational science2025

Investigating research study participant compensation practices at a California academic and research institution.

Mariam Carson, Paula Fleisher, Rana Barar, Li Zhang, Elizabeth Tioupine, Hilary Seligman

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariam CarsonSchool of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-0630-2881
Paula FleisherClinical and Translational Science Institute, University of California San Francisco, San Francisco, CA, USA.
Rana BararClinical and Translational Science Institute, University of California San Francisco, San Francisco, CA, USA.
Li ZhangDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Elizabeth TioupineInstitutional Review Board, University of California San Francisco, San Francisco, CA, USA.
Hilary SeligmanClinical and Translational Science Institute, University of California San Francisco, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: While providing compensation for participation in research studies is common, there is an ongoing debate surrounding compensation models and how they can be equitably applied. This work attempts to better understand the landscape of research compensation by evaluating factors associated with compensation of research study participants across instiutional review board (IRB)-approved studies at a single academic institution in California. Methods: We extracted all IRB applications for social, behavioral, educational, and public policy research studies between January 1, 2019, and December 31, 2021, at the University of California, San Francisco. Compensation amounts, time estimates for participation, and location of study activities (hybrid, remote, in-person) were extracted from free text entries in the IRB application and reorganized into discrete variables. Multivariable logistic regression was used to assess factors associated with receiving payment after adjusting for time. Results: We analyzed 403 unique IRB applications. Studies held at public hospitals and clinics were more likely to provide compensation to study participants, whereas studies held at the university hospitals and clinics were less likely to provide compensation. Unfunded studies also were less likely to provide compensation to research study participants. While participants that were classified as "economically/educationally disadvantaged" and "unable to read, speak, or understand English" within the institution's IRB application were more likely to receive compensation, those that had "diminished capacity to consent" were less likely to receive compensation. Conclusions: While there are multiple frameworks for compensation, there is still significant variability in compensation strategies. Institutions should center equity in considering standardized approaches to compensation for research participation.

Indexed as

ethicsinstitutional review boardIRBresearchresearch compensationResearch participantresearch reimbursementstudy participant

Identifiers

PMID40395386
PMCPMC12089853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.